Advertisement

The Association of Postoperative Osteoporosis Therapy With Periprosthetic Fracture Risk in Patients Undergoing Arthroplasty for Femoral Neck Fractures

Published:October 31, 2022DOI:https://doi.org/10.1016/j.arth.2022.10.042

      Abstract

      Background

      Displaced femoral neck fractures in older adults are generally treated with hip arthroplasty. One concern following hip arthroplasty is the risk for periprosthetic fractures (PPFs). Most patients who have hip fractures are candidates for antiosteoporotic therapy, but the impact of this treatment on PPFs is unknown. Therefore, the primary objective of this study was to evaluate whether patients treated with antiosteoporotic medical therapy had lower odds of PPFs following arthroplasty for hip fracture.

      Methods

      Patients at least 65 years old who underwent hip arthroplasty for femoral neck fractures from 2010 to 2020 were identified in a national database. Patients were stratified based on whether they initiated antiosteoporotic therapy within 1 year of hip arthroplasty. Minimum follow-up was 1 year, and maximum follow-up was 10.6 years. The primary endpoint was cumulative incidence of PPF as determined using Kaplan–Meier and Cox proportional hazards regression analyses. Overall, 2,026 patients who underwent arthroplasty for femoral neck fracture received antiosteoporotic medications within 1 year following surgery (mean follow up 4.8 years; range 1.0 to 10.6 years) and 33,639 patients did not (mean follow up 4.1 years; range 1.1 to 10.3 years).

      Results

      The 10-year cumulative incidence of PPF for patients treated for osteoporosis was 3.88% compared to 5.92% for those who were untreated (P < .001). Adjusting for covariates, patients who received osteoporosis treatment had a significantly lower risk for PPF than those who were untreated (hazard ratio (HR): 0.663; 95% confidence interval (CI): 0.465-0.861; P = .038).

      Conclusion

      The present study suggests that osteoporosis treatment is associated with lower incidence of PPF following hip arthroplasty for femoral neck fractures. Treatment of osteoporosis should be initiated in eligible patients who sustain a femoral neck fracture, especially those who undergo hip arthroplasty.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Arthroplasty
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • CDC
        Hip fractures among older adults.
        ([accessed 19.07.22])
        • Gullberg B.
        • Johnell O.
        • Kanis J.A.
        World-wide projections for hip fracture.
        Osteoporos Int. 1997; 7: 407-413https://doi.org/10.1007/pl00004148
        • Hayes W.C.
        • Myers E.R.
        • Morris J.N.
        • Gerhart T.N.
        • Yett H.S.
        • Lipsitz L.A.
        Impact near the hip dominates fracture risk in elderly nursing home residents who fall.
        Calcif Tissue Int. 1993; 52: 192-198https://doi.org/10.1007/BF00298717
        • Brunner L.C.
        • Eshilian-Oates L.
        • Kuo T.Y.
        Hip fractures in adults.
        Am Fam Physician. 2003; 67: 537-542
        • Adeyemi A.
        • Delhougne G.
        Incidence and economic burden of intertrochanteric fracture: a Medicare claims database analysis.
        JB JS Open Access. 2019; 4: e0045https://doi.org/10.2106/JBJS.OA.18.00045
        • Dyer S.M.
        • Crotty M.
        • Fairhall N.
        • Magaziner J.
        • Beaupre L.A.
        • Cameron I.D.
        • et al.
        A critical review of the long-term disability outcomes following hip fracture.
        BMC Geriatr. 2016; 16: 158https://doi.org/10.1186/s12877-016-0332-0
        • Florschutz A.V.
        • Langford J.R.
        • Haidukewych G.J.
        • Koval K.J.
        Femoral neck fractures: current management.
        J Orthop Trauma. 2015; 29: 121-129https://doi.org/10.1097/BOT.0000000000000291
        • Miyamoto R.G.
        • Kaplan K.M.
        • Levine B.R.
        • Egol K.A.
        • Zuckerman J.D.
        Surgical management of hip fractures: an evidence-based review of the literature. I: femoral neck fractures.
        J Am Acad Orthop Surg. 2008; 16: 596-607https://doi.org/10.5435/00124635-200810000-00005
        • Suarez J.C.
        • Arguelles W.
        • Saxena A.
        • Rivera P.
        • Parris D.
        • Veledar E.
        Hemiarthroplasty vs total hip arthroplasty for femoral neck fractures: 2010-2017 trends in complication rates.
        J Arthroplasty. 2020; 35: S262-S267https://doi.org/10.1016/j.arth.2020.02.040
        • Fernandez M.A.
        • Achten J.
        • Parsons N.
        • Griffin X.L.
        • Png M.-E.
        • Gould J.
        • et al.
        Cemented or uncemented hemiarthroplasty for intracapsular hip fracture.
        N Engl J Med. 2022; 386: 521-530https://doi.org/10.1056/NEJMoa2108337
        • Grammatopoulos G.
        • Wilson H.A.
        • Kendrick B.J.L.
        • Pulford E.C.
        • Lippett J.
        • Deakin M.
        • et al.
        Hemiarthroplasty using cemented or uncemented stems of proven design: a comparative study.
        Bone Joint J. 2015; 97-B: 94-99https://doi.org/10.1302/0301-620X.97B1.34138
        • Kristensen T.B.
        • Dybvik E.
        • Kristoffersen M.
        • Dale H.
        • Engesæter L.B.
        • Furnes O.
        • et al.
        Cemented or uncemented hemiarthroplasty for femoral neck fracture? Data from the Norwegian hip fracture register.
        Clin Orthop Relat Res. 2020; 478: 90-100https://doi.org/10.1097/CORR.0000000000000826
        • Langslet E.
        • Frihagen F.
        • Opland V.
        • Madsen J.E.
        • Nordsletten L.
        • Figved W.
        Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures: 5-year followup of a randomized trial.
        Clin Orthop Relat Res. 2014; 472: 1291-1299https://doi.org/10.1007/s11999-013-3308-9
        • Taylor F.
        • Wright M.
        • Zhu M.
        Hemiarthroplasty of the hip with and without cement: a randomized clinical trial.
        J Bone Joint Surg Am. 2012; 94: 577-583https://doi.org/10.2106/JBJS.K.00006
        • Le Manach Y.
        • Collins G.
        • Bhandari M.
        • Bessissow A.
        • Boddaert J.
        • Khiami F.
        • et al.
        Outcomes after hip fracture surgery compared with elective total hip replacement.
        JAMA. 2015; 314: 1159-1166https://doi.org/10.1001/jama.2015.10842
        • Drew J.M.
        • Griffin W.L.
        • Odum S.M.
        • Van Doren B.
        • Weston B.T.
        • Stryker L.S.
        Survivorship after periprosthetic femur fracture: factors affecting outcome.
        J Arthroplasty. 2016; 31: 1283-1288https://doi.org/10.1016/j.arth.2015.11.038
        • Bhattacharyya T.
        • Chang D.
        • Meigs J.B.
        • Estok 2nd, D.M.
        • Malchau H.
        Mortality after periprosthetic fracture of the femur.
        J Bone Joint Surg Am. 2007; 89: 2658-2662https://doi.org/10.2106/JBJS.F.01538
        • Jennison T.
        • Yarlagadda R.
        Mortality in patients sustaining a periprosthetic fracture following a hemiarthroplasty.
        J Orthop. 2018; 15: 798-801https://doi.org/10.1016/j.jor.2018.05.031
        • Phillips J.R.A.
        • Moran C.G.
        • Manktelow A.R.J.
        Periprosthetic fractures around hip hemiarthroplasty performed for hip fracture.
        Injury. 2013; 44: 757-762https://doi.org/10.1016/j.injury.2012.09.015
        • Bauer D.C.
        Osteoporosis treatment after hip fracture: bad news and getting worse.
        JAMA Netw Open. 2018; 1: e180844https://doi.org/10.1001/jamanetworkopen.2018.0844
        • Cosman F.
        Anabolic and antiresorptive therapy for osteoporosis: combination and sequential approaches.
        Curr Osteoporos Rep. 2014; 12: 385-395https://doi.org/10.1007/s11914-014-0237-9
        • Bawa H.S.
        • Weick J.
        • Dirschl D.R.
        Anti-osteoporotic therapy after fragility fracture lowers rate of subsequent fracture: analysis of a large population sample.
        J Bone Joint Surg Am. 2015; 97: 1555-1562https://doi.org/10.2106/JBJS.N.01275
        • Wang C.-Y.
        • Fu S.-H.
        • Yang R.-S.
        • Chen L.-K.
        • Shen L.-J.
        • Hsiao F.-Y.
        Timing of anti-osteoporosis medications initiation after a hip fracture affects the risk of subsequent fracture: a nationwide cohort study.
        Bone. 2020; 138: 115452https://doi.org/10.1016/j.bone.2020.115452
        • Black D.M.
        • Delmas P.D.
        • Eastell R.
        • Reid I.R.
        • Boonen S.
        • Cauley J.A.
        • et al.
        Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
        N Engl J Med. 2007; 356: 1809-1822https://doi.org/10.1056/NEJMoa067312
        • Cosman F.
        • Crittenden D.B.
        • Adachi J.D.
        • Binkley N.
        • Czerwinski E.
        • Ferrari S.
        • et al.
        Romosozumab treatment in postmenopausal women with osteoporosis.
        N Engl J Med. 2016; 375: 1532-1543https://doi.org/10.1056/NEJMoa1607948
        • Ross A.J.
        • Ross B.J.
        • Lee O.C.
        • Guild 3rd, G.N.
        • Sherman W.F.
        The impact of prior fragility fractures on complications after total hip arthroplasty: a propensity score-matched cohort study.
        Arthroplast Today. 2021; 11: 41-48https://doi.org/10.1016/j.artd.2021.07.008
        • Ip T.P.
        • Leung J.
        • Kung A.W.C.
        Management of osteoporosis in patients hospitalized for hip fractures.
        Osteoporos Int. 2010; 21: S605-S614https://doi.org/10.1007/s00198-010-1398-8
        • Tai T.-W.
        • Li C.-C.
        • Huang C.-F.
        • Chan W.P.
        • Wu C.-H.
        Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: a nationwide population study.
        Bone. 2022; 154: 116216https://doi.org/10.1016/j.bone.2021.116216
        • Wang P.-W.
        • Li Y.-Z.
        • Zhuang H.-F.
        • Yu H.-M.
        • Cai S.-Q.
        • Xu H.
        • et al.
        Anti-osteoporosis medications associated with decreased mortality after hip fracture.
        Orthop Surg. 2019; 11: 777-783https://doi.org/10.1111/os.12517
        • Bouxsein M.L.
        • Kaufman J.
        • Tosi L.
        • Cummings S.
        • Lane J.
        • Johnell O.
        Recommendations for optimal care of the fragility fracture patient to reduce the risk of future fracture.
        J Am Acad Orthop Surg. 2004; 12: 385-395https://doi.org/10.5435/00124635-200411000-00003
        • Ross B.J.
        • Lee O.C.
        • Harris M.B.
        • Dowd T.C.
        • Savoie 3rd, F.H.
        • Sherman W.F.
        Rates of osteoporosis management and secondary preventative treatment after primary fragility fractures.
        JB JS Open Access. 2021; 6: e20.00142https://doi.org/10.2106/JBJS.OA.20.00142
        • Patsiogiannis N.
        • Kanakaris N.K.
        • Giannoudis P.V.
        Periprosthetic hip fractures: an update into their management and clinical outcomes.
        EFORT Open Rev. 2021; 6: 75-92https://doi.org/10.1302/2058-5241.6.200050
        • Abdel M.P.
        • Watts C.D.
        • Houdek M.T.
        • Lewallen D.G.
        • Berry D.J.
        Epidemiology of periprosthetic fracture of the femur in 32 644 primary total hip arthroplasties: a 40-year experience.
        Bone Joint J. 2016; 98-B: 461-467https://doi.org/10.1302/0301-620X.98B4.37201
        • Marsland D.
        • Mears S.C.
        A review of periprosthetic femoral fractures associated with total hip arthroplasty.
        Geriatr Orthop Surg Rehabil. 2012; 3: 107-120https://doi.org/10.1177/2151458512462870
        • Black D.M.
        • Geiger E.J.
        • Eastell R.
        • Vittinghoff E.
        • Li B.H.
        • Ryan D.S.
        • et al.
        Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates.
        N Engl J Med. 2020; 383: 743-753https://doi.org/10.1056/NEJMoa1916525
        • MacKenzie S.A.
        • Ng R.T.
        • Snowden G.
        • Powell-Bowns M.F.R.
        • Duckworth A.D.
        • Scott C.E.H.
        Periprosthetic atypical femoral fractures exist and are associated with duration of bisphosphonate therapy.
        Bone Joint J. 2019; 101-B: 1285-1291https://doi.org/10.1302/0301-620X.101B10.BJJ-2019-0599.R2
        • Bottai V.
        • De Paola G.
        • Celli F.
        • Lazzerini I.
        • Ortenzi V.
        • Naccarato A.G.
        • et al.
        Histological study of atraumatic periprosthetic fractures: does atypical periprosthetic fracture exist?.
        Clin Cases Miner Bone Metab. 2017; 14: 136-139https://doi.org/10.11138/ccmbm/2017.14.1.136
        • Bhattacharyya R.
        • Spence S.
        • O’Neill G.
        • Periasamy K.
        Bisphosphonate-induced periprosthetic fracture: a cause of painful total hip arthroplasty.
        Case Rep Surg. 2014; 2014: 631709https://doi.org/10.1155/2014/631709
        • Baba T.
        • Uchino M.
        • Ochi H.
        • Ikuta T.
        • Saita Y.
        • Hagino H.
        • et al.
        Atypical periprosthetic femoral fractures after arthroplasty for fracture are at high risk of complications.
        Sci Rep. 2021; 11: 14378https://doi.org/10.1038/s41598-021-93574-1
        • Ofa S.A.
        • Ross A.J.
        • Ross B.J.
        • Lee O.C.
        • Sherman W.F.
        Complication rates of hemiarthroplasty conversion to total hip arthroplasty versus primary total hip arthroplasty.
        Orthop Rev (Pavia). 2021; 13: 25539https://doi.org/10.52965/001c.25539